Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α.
Saved in:
| Title: | Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α. |
|---|---|
| Authors: | Citro S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy. simona.citro@ieo.it., Bellini A; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy., Miccolo C; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy., Ghiani L; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy., Carey TE; Department of Otolaryngology-Head and Neck Surgery, Department of Pharmacology, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA., Chiocca S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy. susanna.chiocca@ieo.it. |
| Source: | British journal of cancer [Br J Cancer] 2019 Mar; Vol. 120 (6), pp. 658-667. Date of Electronic Publication: 2019 Feb 15. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30765872 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Citro+S%22">Citro S</searchLink>; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy. simona.citro@ieo.it.<br /><searchLink fieldCode="AU" term="%22Bellini+A%22">Bellini A</searchLink>; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Miccolo+C%22">Miccolo C</searchLink>; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Ghiani+L%22">Ghiani L</searchLink>; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Carey+TE%22">Carey TE</searchLink>; Department of Otolaryngology-Head and Neck Surgery, Department of Pharmacology, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Chiocca+S%22">Chiocca S</searchLink>; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy. susanna.chiocca@ieo.it. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2019 Mar; Vol. 120 (6), pp. 658-667. <i>Date of Electronic Publication: </i>2019 Feb 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30765872 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41416-019-0394-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 658 Titles: – TitleFull: Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Citro S – PersonEntity: Name: NameFull: Bellini A – PersonEntity: Name: NameFull: Miccolo C – PersonEntity: Name: NameFull: Ghiani L – PersonEntity: Name: NameFull: Carey TE – PersonEntity: Name: NameFull: Chiocca S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2019 Mar Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1532-1827 Numbering: – Type: volume Value: 120 – Type: issue Value: 6 Titles: – TitleFull: British journal of cancer Type: main |
| ResultId | 1 |